CompaniesTheseus Pharmaceuticals

Theseus Pharmaceuticals

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

32

By Phase

PHASE1/PHASE2: 1

By Status

TERMINATED: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2021

2022

2023

2024

2025

Today

Hover over trial bars to see details

Recent Trials

NCT05160168Lead Sponsor

A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

PHASE1/PHASE2Terminated

32 participants

Started: Jan 3, 2022 · Completed: Feb 2, 2024

Funding History (20)

8-K

Feb 14, 2024

8-K

Dec 22, 2023

8-K

Dec 4, 2023

8-K

Nov 27, 2023

8-K

Nov 13, 2023

8-K

Oct 31, 2023

8-K

Aug 10, 2023

8-K

Jul 13, 2023

8-K

Jun 9, 2023

8-K

May 25, 2023

Related Companies

Concentra Pharmaceuticals

acquired